statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	471
SG - Singapore	175
CN - Cina	103
BR - Brasile	90
SE - Svezia	85
VN - Vietnam	37
IT - Italia	31
DE - Germania	30
FR - Francia	29
IN - India	22
IE - Irlanda	20
JP - Giappone	18
ID - Indonesia	16
GB - Regno Unito	15
TR - Turchia	14
HK - Hong Kong	9
RU - Federazione Russa	8
FI - Finlandia	7
CA - Canada	6
BD - Bangladesh	5
IQ - Iraq	5
AR - Argentina	4
EC - Ecuador	4
VE - Venezuela	4
ZA - Sudafrica	4
AT - Austria	3
CH - Svizzera	3
DZ - Algeria	3
PY - Paraguay	3
SA - Arabia Saudita	3
UA - Ucraina	3
UZ - Uzbekistan	3
AE - Emirati Arabi Uniti	2
AM - Armenia	2
AZ - Azerbaigian	2
BO - Bolivia	2
CO - Colombia	2
LB - Libano	2
MY - Malesia	2
PE - Perù	2
PK - Pakistan	2
PS - Palestinian Territory	2
AU - Australia	1
BY - Bielorussia	1
CZ - Repubblica Ceca	1
ES - Italia	1
ET - Etiopia	1
HU - Ungheria	1
IL - Israele	1
JO - Giordania	1
KE - Kenya	1
LA - Repubblica Popolare Democratica del Laos	1
LU - Lussemburgo	1
LV - Lettonia	1
MA - Marocco	1
MX - Messico	1
NL - Olanda	1
NO - Norvegia	1
OM - Oman	1
PA - Panama	1
PL - Polonia	1
RO - Romania	1
RS - Serbia	1
UY - Uruguay	1
YE - Yemen	1
Totale	1.276

Nome	#
C-Met/MIR-130b axis as novel mechanism and biomarker for castration resistance state acquisition	156
Blocking the APRIL circuit enhances acute myeloid leukemia cell chemosensitivity	153
C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition	142
The inhibition of the highly expressed mir-221 and mir-222 impairs the growth of prostate carcinoma xenografts in mice	134
The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities	121
MicroRNAs and prostate cancer	112
MicroRNAs and prostate cancer: From preclinical research to translational oncology	106
A microRNA code for prostate cancer metastasis	97
Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer	94
BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition	92
Functional role of microRNAs in prostate cancer and therapeutic Opportunities	84
Totale	1.291

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	3	0	0	0	0	0	0	0	0	0	0	1	2
2021/2022	100	5	8	6	8	10	3	2	15	3	6	17	17
2022/2023	232	29	35	20	17	29	19	4	20	33	14	11	1
2023/2024	112	7	32	1	11	6	2	7	14	1	0	22	9
2024/2025	224	10	4	14	11	11	19	0	14	46	33	41	21
2025/2026	457	75	20	30	75	77	15	76	22	36	31	0	0
Totale													1.291

IRIS UniCatt